Targeting RNA with peptidomimetic oligomers in human cells

Area of Science:

• Molecular Biology
• Virology
• Medicinal Chemistry

Background:

• HIV-1 replication depends on Tat protein binding to the TAR RNA structure.
• Targeting essential protein-RNA interactions is a key strategy for antiviral drug development.

Purpose of the Study:

• To investigate novel peptidomimetics as inhibitors of HIV-1 Tat-TAR RNA interactions.
• To evaluate the efficacy of oligourea and oligocarbamate in blocking HIV-1 transcriptional activation.

Main Methods:

• Synthesis and characterization of TAR RNA-binding peptidomimetics (oligourea, oligocarbamate).
• Assay of peptidomimetic inhibition of Tat-mediated transcriptional activation in human cells.
• Determination of IC50 values for inhibition.

Main Results:

• Oligourea and oligocarbamate demonstrated significant inhibition of Tat-mediated transcriptional activation.
• IC50 values were approximately 0.5 microM for oligourea and 1 microM for oligocarbamate.
• These peptidomimetics effectively target specific RNA structures.

Conclusions:

• Oligourea and oligocarbamate are effective inhibitors of HIV-1 Tat-TAR RNA interactions.
• Peptidomimetics targeting RNA structures represent a promising class of antiviral agents.
• This approach offers a novel method for controlling cellular processes involving protein-RNA interactions in vivo.